Mecloxamine Citrate is the citrate salt form of Mecloxamine, an anticholinergic compound associated with sedative and hypnotic pharmacological activity.
Mecloxamine has been associated with combination pharmaceutical applications involving headache and migraine management. Its anticholinergic activity is related to inhibition of acetylcholine-mediated activity at muscarinic receptors.
Swapnroop Drugs and Pharmaceuticals supplies Mecloxamine Citrate API for qualified pharmaceutical, research, and formulation requirements with emphasis on product traceability, controlled documentation, quality consistency, and secure supply-chain management.
Mecloxamine Citrate API is primarily associated with:
Mecloxamine has historically been associated with combination preparations involving caffeine, ergotamine, and acetaminophen for headache and migraine-related applications.
Mecloxamine Citrate API is supplied in secure, pharmaceutical-grade packaging selected according to product stability, quantity, safety, and customer requirements.
Packaging options and shipment quantities are provided based on approved commercial, quality, and regulatory requirements.
Store Mecloxamine Citrate API in tightly closed, appropriately labeled containers under recommended controlled conditions.
Protect the material from excessive moisture, heat, and direct light. Handling should be performed by trained personnel according to approved pharmaceutical material handling procedures and applicable safety requirements.
Swapnroop Drugs and Pharmaceuticals is committed to supplying pharmaceutical raw materials with a focus on:
As a pharmaceutical raw material supplier in India, Swapnroop Drugs and Pharmaceuticals provides Mecloxamine Citrate API bulk supply and export support for qualified pharmaceutical, research, formulation, and industrial customers.
For Mecloxamine Citrate API price, specification, COA availability, MOQ, packaging, and export enquiries, contact our pharmaceutical sales team.
Email: enquiry@sdp.org.in
Website: www.sdp.org.in